20H11
20H11
规格:
货期:
编号:TS212971
品牌:Testobio
| 产品名称： | 20H11 |
|---|---|
| 商品货号： | TS212971 |
| Organism： | Homo sapiens, human |
| Tissue： | spleen |
| Cell Type： | B lymphocyte; Epstein-Barr virus (EBV) transformed |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 Cells Contain HERPESVIRUS
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody reacts with P aeruginosa Fisher immunotypes 2, 6 and 7. The antibody cross-reacts extensively with clinical isolates of P. aeruginosa bearng type b flagella. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Clinical Data： | Peripheral blood B cells from a patient immunized with high molecular weight polysaccharide from P. aeruginosa were transformed with Epstein-Barr virus. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against Pseudomonas aeruginosa (flagella type b) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against Pseudomonas aeruginosa (flagella type b) |
| Comments： | Peripheral blood B cells from a patient immunized with high molecular weight polysaccharide from P. aeruginosa were transformed with Epstein-Barr virus. The antibody reacts with P aeruginosa Fisher immunotypes 2, 6 and 7. The antibody cross-reacts extensively with clinical isolates of P. aeruginosa bearng type b flagella. |
| Complete Growth Medium： | Iscoves modified Dulbeccos medium with 2 mM L-glutamine, 85%; heat-inactivated fetal bovine serum, 15%
|
| Subculturing： | Medium Renewal: Every 3 to 4 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Population Doubling Time： | 24 to 36 hrs |
| Name of Depositor： | Genetic Systems Corp. |
| Deposited As： | Homo sapiens |
| U.S. Patent Number： | |
| References： | Rosok MJ, Lostrom ME. Monoclonal antibodies to Pseudomonas aeruginosa flagella. US Patent 4,834,976 dated May 30 1989 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
20H11
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | 20H11 |
|---|---|
| 商品货号： | TS212971 |
| Organism： | Homo sapiens, human |
| Tissue： | spleen |
| Cell Type： | B lymphocyte; Epstein-Barr virus (EBV) transformed |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 Cells Contain HERPESVIRUS
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody reacts with P aeruginosa Fisher immunotypes 2, 6 and 7. The antibody cross-reacts extensively with clinical isolates of P. aeruginosa bearng type b flagella. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Clinical Data： | Peripheral blood B cells from a patient immunized with high molecular weight polysaccharide from P. aeruginosa were transformed with Epstein-Barr virus. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against Pseudomonas aeruginosa (flagella type b) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against Pseudomonas aeruginosa (flagella type b) |
| Comments： | Peripheral blood B cells from a patient immunized with high molecular weight polysaccharide from P. aeruginosa were transformed with Epstein-Barr virus. The antibody reacts with P aeruginosa Fisher immunotypes 2, 6 and 7. The antibody cross-reacts extensively with clinical isolates of P. aeruginosa bearng type b flagella. |
| Complete Growth Medium： | Iscoves modified Dulbeccos medium with 2 mM L-glutamine, 85%; heat-inactivated fetal bovine serum, 15%
|
| Subculturing： | Medium Renewal: Every 3 to 4 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Population Doubling Time： | 24 to 36 hrs |
| Name of Depositor： | Genetic Systems Corp. |
| Deposited As： | Homo sapiens |
| U.S. Patent Number： | |
| References： | Rosok MJ, Lostrom ME. Monoclonal antibodies to Pseudomonas aeruginosa flagella. US Patent 4,834,976 dated May 30 1989 |
